New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis

Flavio Vincenti, Gian Marco Ghiggeri

Research output: Contribution to journalArticle

94 Citations (Scopus)

Abstract

Recurrent focal glomerulosclerosis (FSGS) in renal allografts has remained a frustrating and enigmatic disease. Recent studies on gene mutations encoding podocin and other components of the slit-diaphragm in patients with native kidney nephrotic syndrome have underscored the heterogenecity of the idiopathic form of FSGS. While familial FSGS rarely recurs following transplantation, the sporadic variety of FSGS is associated with a 30% recurrence rate. The patients with the sporadic variety of FSGS who have homozygous or complex heterozygous podocin mutations have a low recurrence rate. In the other patients with sporadic FSGS, a more complex and likely multifactorial etiology accounts for the recurrence of FSGS. The role of CD80 expression on podocytes is intriguing but requires confirmation in kidney biopsies of patients with recurrent FSGS. Recent findings on podocin genomics, the permeability factor and CD80 expression may ultimately lead to a better understanding of recurrent FSGS as well as a more effective approach to its prevention and treatment.

Original languageEnglish
Pages (from-to)1179-1185
Number of pages7
JournalAmerican Journal of Transplantation
Volume5
Issue number6
DOIs
Publication statusPublished - Jun 2005

Fingerprint

Focal Segmental Glomerulosclerosis
Kidney
Recurrence
Podocytes
Mutation
Nephrotic Syndrome
Therapeutics
Genomics
Diaphragm
Allografts
Permeability
Transplantation
Biopsy
Genes
NPHS2 protein

Keywords

  • Focal glomerulosclerosis
  • Permeability factor
  • Recurrent disease

ASJC Scopus subject areas

  • Immunology

Cite this

New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis. / Vincenti, Flavio; Ghiggeri, Gian Marco.

In: American Journal of Transplantation, Vol. 5, No. 6, 06.2005, p. 1179-1185.

Research output: Contribution to journalArticle

@article{c25e1423f43c4a4d8e0d90a681249e68,
title = "New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis",
abstract = "Recurrent focal glomerulosclerosis (FSGS) in renal allografts has remained a frustrating and enigmatic disease. Recent studies on gene mutations encoding podocin and other components of the slit-diaphragm in patients with native kidney nephrotic syndrome have underscored the heterogenecity of the idiopathic form of FSGS. While familial FSGS rarely recurs following transplantation, the sporadic variety of FSGS is associated with a 30{\%} recurrence rate. The patients with the sporadic variety of FSGS who have homozygous or complex heterozygous podocin mutations have a low recurrence rate. In the other patients with sporadic FSGS, a more complex and likely multifactorial etiology accounts for the recurrence of FSGS. The role of CD80 expression on podocytes is intriguing but requires confirmation in kidney biopsies of patients with recurrent FSGS. Recent findings on podocin genomics, the permeability factor and CD80 expression may ultimately lead to a better understanding of recurrent FSGS as well as a more effective approach to its prevention and treatment.",
keywords = "Focal glomerulosclerosis, Permeability factor, Recurrent disease",
author = "Flavio Vincenti and Ghiggeri, {Gian Marco}",
year = "2005",
month = "6",
doi = "10.1111/j.1600-6143.2005.00968.x",
language = "English",
volume = "5",
pages = "1179--1185",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis

AU - Vincenti, Flavio

AU - Ghiggeri, Gian Marco

PY - 2005/6

Y1 - 2005/6

N2 - Recurrent focal glomerulosclerosis (FSGS) in renal allografts has remained a frustrating and enigmatic disease. Recent studies on gene mutations encoding podocin and other components of the slit-diaphragm in patients with native kidney nephrotic syndrome have underscored the heterogenecity of the idiopathic form of FSGS. While familial FSGS rarely recurs following transplantation, the sporadic variety of FSGS is associated with a 30% recurrence rate. The patients with the sporadic variety of FSGS who have homozygous or complex heterozygous podocin mutations have a low recurrence rate. In the other patients with sporadic FSGS, a more complex and likely multifactorial etiology accounts for the recurrence of FSGS. The role of CD80 expression on podocytes is intriguing but requires confirmation in kidney biopsies of patients with recurrent FSGS. Recent findings on podocin genomics, the permeability factor and CD80 expression may ultimately lead to a better understanding of recurrent FSGS as well as a more effective approach to its prevention and treatment.

AB - Recurrent focal glomerulosclerosis (FSGS) in renal allografts has remained a frustrating and enigmatic disease. Recent studies on gene mutations encoding podocin and other components of the slit-diaphragm in patients with native kidney nephrotic syndrome have underscored the heterogenecity of the idiopathic form of FSGS. While familial FSGS rarely recurs following transplantation, the sporadic variety of FSGS is associated with a 30% recurrence rate. The patients with the sporadic variety of FSGS who have homozygous or complex heterozygous podocin mutations have a low recurrence rate. In the other patients with sporadic FSGS, a more complex and likely multifactorial etiology accounts for the recurrence of FSGS. The role of CD80 expression on podocytes is intriguing but requires confirmation in kidney biopsies of patients with recurrent FSGS. Recent findings on podocin genomics, the permeability factor and CD80 expression may ultimately lead to a better understanding of recurrent FSGS as well as a more effective approach to its prevention and treatment.

KW - Focal glomerulosclerosis

KW - Permeability factor

KW - Recurrent disease

UR - http://www.scopus.com/inward/record.url?scp=20544465592&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20544465592&partnerID=8YFLogxK

U2 - 10.1111/j.1600-6143.2005.00968.x

DO - 10.1111/j.1600-6143.2005.00968.x

M3 - Article

C2 - 15888021

AN - SCOPUS:20544465592

VL - 5

SP - 1179

EP - 1185

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

IS - 6

ER -